Second-line tests in the differential diagnosis of neoplastic and non-neoplastic hypercortisolism: a systematic review and meta-analysis.
Mondin A, Barbot M, Voltan G, Tizianel I, Vedolin CK, Mazzeo P, Lazzara M, Boscaro M, Scaroni C, Ceccato F.
Mondin A, et al.
J Endocrinol Invest. 2023 Oct;46(10):1947-1959. doi: 10.1007/s40618-023-02099-z. Epub 2023 Apr 20.
J Endocrinol Invest. 2023.
PMID: 37079177
Free PMC article.
Review.
PURPOSE: The clinical and hormonal overlap between neoplastic (CS) and non-neoplastic (NNH/pCS) hypercortisolism is a challenge. Various dynamic tests have been proposed to allow an early discrimination between these conditions, but to date there is no agreement on …
PURPOSE: The clinical and hormonal overlap between neoplastic (CS) and non-neoplastic (NNH/pCS) hypercortisolism is a challeng …